Usefulness of pamidronate in the treatment of Charcot's arthropathy;Utilidad del pamidronato en el tratamiento de la artropatía de Charcot

Reumatologia Clinica

Volumn 3, Issue 6, 2007, Pages 257-261

  Moreno, Mireia ^a   Gratacós, Jordi ^a   Casado, Enrique ^a   Galisteo, Carlos ^a   Orellana, Cristóbal ^a   Larrosa, Marta ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Bisphosphonates; Charcot; Neuroarthropathy; Pamidronato

Indexed keywords

PAMIDRONIC ACID; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROPATHIC JOINT DISEASE; SCINTIGRAPHY; TREATMENT RESPONSE; URINALYSIS;

EID: 38649120531     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(07)73700-2     Document Type: Article

References (11)

1. Jeffcoate WJ, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366:2058-61.
2. Selby PL, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11:28-31.
3. Pitocco D, Caputo S, Mancini L, Collina CM, Manto A, Caradonna P, et al. Six-months treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28:1214-5.
4. Anderson JJ, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43:285-9.
5. Jude EB, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032-7.
6. Jude EB. Medical treatment of Charcot's arthropathy. J Am Pediatr Med Assoc. 2002;92:381-3.
7. Tucci JR, Bontha S. Intravenously administered pamidronate in the treatment of Paget's disease of bone. Endocr Pract. 2001;7:423-9.
8. Siris ES. Paget's disease of bone. J Bone Miner Res. 1998;13:1061-5.
9. Gough A, Abraha H, Li F, Purewal TS, Foster AV, Watkins PJ, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chroic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14:527-31.
10. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085-96.
11. Mc Gill M, Bolton T, Ionnou K, Uren R, Yue DK. Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia. 2000;43:481-4.